Danaher Corporation $DHR Shares Bought by National Pension Service

Key Points

• National Pension Service increased its Danaher stake by 2.8% in the second quarter, purchasing 40,205 additional shares to own 1.5 million shares valued at approximately $285.9 million. Institutional investors collectively hold 79.05% of Danaher’s outstanding stock.
• Danaher exceeded quarterly expectations, reporting $1.94 in adjusted earnings per share versus the $1.85 consensus and revenue of $6.26 billion versus estimates of $6.12 billion. Revenue rose 5.5% year over year.
• Analysts maintain a generally positive view, with the stock carrying a consensus “Moderate Buy” rating and an average price target of $228.91, compared with its recent price of $205.06.

National Pension Service grew its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 2.8% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,500,949 shares of the conglomerate's stock after buying an additional 40,205 shares during the period. National Pension Service owned 0.21% of Danaher worth $285,901,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Main Street Group LTD purchased a new position in shares of Danaher in the 1st quarter worth about $25,000. N.E.W. Advisory Services LLC acquired a new stake in Danaher during the 2nd quarter worth approximately $25,000. JPL Wealth Management LLC purchased a new position in Danaher in the third quarter valued at approximately $25,000. WFA of San Diego LLC purchased a new stake in Danaher during the second quarter worth approximately $26,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in shares of Danaher in the fourth quarter worth $27,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Price Performance

DHR opened at $205.06 on Thursday. The company has a fifty day simple moving average of $202.55 and a 200 day simple moving average of $192.08. The firm has a market cap of $144.15 billion, a price-to-earnings ratio of 36.42, a PEG ratio of 2.56 and a beta of 0.78. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts' consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm's revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.77 EPS. Equities research analysts expect that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on DHR shares. Piper Sandler started coverage on shares of Danaher in a report on Thursday, June 11th. They set a "neutral" rating and a $200.00 target price on the stock. DZ Bank initiated coverage on Danaher in a research report on Wednesday, June 3rd. They issued a "buy" rating and a $210.00 price objective on the stock. Wells Fargo & Company reduced their price objective on Danaher from $212.00 to $195.00 and set an "equal weight" rating on the stock in a research note on Wednesday, July 22nd. Guggenheim decreased their target price on Danaher from $235.00 to $200.00 and set a "buy" rating for the company in a research report on Wednesday, July 22nd. Finally, Citigroup started coverage on Danaher in a research note on Tuesday, May 26th. They issued a "buy" rating and a $230.00 target price for the company. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $228.91.

About Danaher

Danaher Corporation NYSE: DHR is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its businesses support pharmaceutical and biotechnology research, biomanufacturing, clinical laboratories and healthcare providers.

The company's portfolio includes bioprocessing technologies, laboratory instruments, consumables, reagents and software. Key businesses include Cytiva, which provides biomanufacturing solutions; Beckman Coulter, which supplies laboratory diagnostics and automation systems; Leica Biosystems, which develops pathology products; and IDT, which provides genomic and nucleic acid products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.